KHPG(SZ:002773) Xin Lang Cai Jing·2025-09-01 05:21Group 1 - The core viewpoint of the news is that Kanghong Pharmaceutical has seen a significant increase in its stock price, with a rise of 5.12% to 42.32 CNY per share, and a total market capitalization of 38.99 billion CNY [1] - Kanghong Pharmaceutical's main business segments include biopharmaceuticals (54.83%), traditional Chinese medicine (32.49%), chemical drugs (12.50%), and others (0.15%) [1] - The company was founded on October 3, 1996, and was listed on June 26, 2015, with its headquarters located in Chengdu, Sichuan Province [1] Group 2 - Longcheng Fund has a significant position in Kanghong Pharmaceutical, with its Longcheng Pharmaceutical Industry Selected Mixed Fund A increasing its holdings by 151.39 thousand shares in the second quarter, bringing the total to 161.64 thousand shares, which represents 4.14% of the fund's net value [2] - The Longcheng Pharmaceutical Industry Selected Mixed Fund A has achieved a return of 120.29% year-to-date, ranking 7th out of 8254 in its category [2] - The fund manager, Liang Furui, has been in position for 315 days, with the fund's total asset size at 1.132 billion CNY and a best return of 110.33% during his tenure [3]